Open-label Adalimumab

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
46	悪性関節リウマチ	55

46. 悪性関節リウマチ

臨床試験数 : 4,356 / 薬物数 : 2,567 - (DrugBank : 415) / 標的遺伝子数 : 192 - 標的パスウェイ数 : 228

trials per page:

Showing 1 to 10 of 55 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-jRCT2071210068 (jRCT2071210068)	09/11/2021	28/09/2021	Abatacept vs Adalimumab in Early, Seropositive, and SE-positive RA	A Randomized, Head-to-head, Single-blind Study to Compare the Response to Treatment with Subcutaneou ...	Rheumatoid Arthritis	Single-blind Treatment Period Arm A Abatacept+MTX Arm B Adalimumab+MTX Open-labelTreatment Period Abatac ...	Maldonado A Michael	NULL	Recruiting	>= 20age old	Not applicable	Both	20	Phase 3	Australia;France;Germany;USA;Taiwan;Japan
2	NCT04171414 (ClinicalTrials.gov)	September 9, 2019	18/9/2019	A Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P17 in Patients With Active Rheuma ...	A Phase III, Open-label, Single-arm, Multiple-dose Study to Evaluate Usability of Subcutaneous Auto- ...	Rheumatoid Arthritis	Biological: CT-P17 SC AI (adalimumab)	Celltrion	PPD	Recruiting	18 Years	70 Years	All	50	Phase 3	Poland
3	NCT04018599 (ClinicalTrials.gov)	July 15, 2019	11/7/2019	Comparison of PK and Tolerability of MSB11022 Administered by AI or PFS	A Phase I, Randomized, Open-label, Parallel-group Study to Determine the Pharmacokinetics, Safety, a ...	Rheumatoid Arthritis;Polyarticular Juvenile Idiopathic Arthritis;Psoriatic Arthritis;Ankylosing Spon ...	Drug: 40 mg MSB11022	Fresenius Kabi SwissBioSim GmbH	PRA Health Sciences	Completed	18 Years	55 Years	All	216	Phase 1	United States
4	EUCTR2019-000660-25-PL (EUCTR)	09/07/2019	20/05/2019	Evaluating Usability of Subcutaneous Auto-injector of CT-P17 in Patients with Moderate to Severe Act ...	A Phase III, Open-label, Single-arm, Multiple-dose Study to Evaluate Usability of Subcutaneous Auto- ...	Moderate to Severe Active Rheumatoid Arthritis MedDRA version: 21.0;Level: PT;Classification code 10 ...	Product Name: CT-P17 Product Code: CT-P17 INN or Proposed INN: ADALIMUMAB	CELLTRION, Inc.	NULL	Not Recruiting			Female: yes Male: yes	60	Phase 3	Poland
5	NCT03100253 (ClinicalTrials.gov)	March 1, 2018	17/3/2017	Rheumatoid Arthritis Treatment After First Anti-TNF INvestiGation	Open-label, Randomized Controlled Trial Comparing Tocilizumab to Anti-TNF Treatment and Discovery of ...	Rheumatoid Arthritis	Drug: Tocilizumab;Drug: Etanercept;Drug: Infliximab;Drug: Adalimumab;Drug: Golimumab;Drug: Certolizu ...	Mario Negri Institute for Pharmacological Research	NULL	Terminated	18 Years	N/A	All	208	Phase 4	Italy
6	EUCTR2016-001987-12-IT (EUCTR)	18/08/2017	05/01/2021	Clinical study aimed to compare tocilizumab to anti-TNF treatment and to discover biomarkers for tre ...	Open-label, randomized controlled trial comparing tocilizumab to anti-TNF treatment and discovery of ...	RHEUMATOID ARTHRITIS MedDRA version: 20.0;Level: LLT;Classification code 10037738;Term: R arthritis; ...	Trade Name: ROACTEMRA - 20 MG/ML CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCI ...	SOCIETA' ITALIANA DI REUMATOLOGIA - SIR	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	208	Phase 4	Italy
7	JPRN-UMIN000024025	2016/10/01	01/10/2016	The clinical impact of methotrexate dose reduction at combination therapy with adalimumabplus methot ...	The clinical impact of methotrexate dose reduction at combination therapy with adalimumabplus methot ...	Rheumatoid Arthritis	receiving 40 mg open-labelADA every other week for 26 weeks with low dose MTX (6mg/week) receiving 4 ...	Search Institute for Bone and Arthritis Disease (SINBAD), Shirahama Foundation for Health and Welfar ...	NULL	Recruiting	20years-old	Not applicable	Male and Female	80	Not applicable	Japan
8	NCT02722044 (ClinicalTrials.gov)	April 2016	23/3/2016	Usability of an AI for M923 in Subjects With Moderate to Severe RA	An Open-labelSingle-arm Multicenter Study to Evaluate Usability of a Subcutaneous (SC) Autoinjector ...	Rheumatoid Arthritis	Biological: M923;Device: Autoinjector	Momenta Pharmaceuticals, Inc.	NULL	Completed	18 Years	N/A	All	33	Phase 3	United States
9	EUCTR2015-002634-41-DE (EUCTR)	25/02/2016	10/11/2015	Long-term study of BI695501 in patients with active rheumatoid arthritis	Long-term assessment of safety, efficacy, pharmacokinetics and immunogenicity of BI 695501 in patien ...	Rheumatoid arthritis MedDRA version: 20.0;Level: PT;Classification code 10039073;Term: Rheumatoid ar ...	Product Code: BI 695501 INN or Proposed INN: - Other descriptive name: BI 695501	Boehringer Ingelheim International GmbH	NULL	Not Recruiting			Female: yes Male: yes	400	Phase 3	Serbia;United States;Estonia;Spain;Thailand;Ukraine;Chile;Russian Federation;Hungary;Malaysia;Poland ...
10	EUCTR2015-002634-41-BG (EUCTR)	24/02/2016	21/12/2015	Long-term study of BI695501 in patients with active rheumatoid arthritis	Long-term assessment of safety, efficacy, pharmacokinetics and immunogenicity of BI 695501 in patien ...	Rheumatoid arthritis MedDRA version: 20.0;Level: PT;Classification code 10039073;Term: Rheumatoid ar ...	Product Code: BI 695501 INN or Proposed INN: - Other descriptive name: BI 695501	Boehringer Ingelheim International GmbH	NULL	Not Recruiting			Female: yes Male: yes	400	Phase 3	Serbia;United States;Estonia;Spain;Thailand;Ukraine;Chile;Russian Federation;Hungary;Malaysia;Poland ...

First Previous1 2 3 4 5 6Next Last